Hydroxyethyl starch 130/0.4 and surgical blood loss
- PMID: 19151311
- DOI: 10.1213/ane.0b013e31818ee38a
Hydroxyethyl starch 130/0.4 and surgical blood loss
Comment on
-
The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.Anesth Analg. 2008 Aug;107(2):382-90. doi: 10.1213/ane.0b013e31817e6eac. Anesth Analg. 2008. PMID: 18633012
Similar articles
-
Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.Anesthesiology. 2003 Jul;99(1):42-7. doi: 10.1097/00000542-200307000-00010. Anesthesiology. 2003. PMID: 12826840 Clinical Trial.
-
Pro: Third-Generation Hydroxyethyl Starch Solution Is Safe and Effective for Plasma Volume Expansion During Cardiac Surgery.J Cardiothorac Vasc Anesth. 2018 Feb;32(1):570-575. doi: 10.1053/j.jvca.2017.08.013. Epub 2017 Aug 12. J Cardiothorac Vasc Anesth. 2018. PMID: 29174121 No abstract available.
-
Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.Braz J Anesthesiol. 2013 Jan;63(1):27-35. doi: 10.1016/j.bjane.2012.03.002. Epub 2013 Aug 7. Braz J Anesthesiol. 2013. PMID: 24565088 Clinical Trial.
-
Is 6% tetrastarch 130kDa (hydroxyethyl starch 130/0.4 or 130/0.42) suitable for severe sepsis?Br J Hosp Med (Lond). 2013 Mar;74(3):178. doi: 10.12968/hmed.2013.74.3.178. Br J Hosp Med (Lond). 2013. PMID: 23665793 Review. No abstract available.
-
Synthetic blood substitutes: where are we and where do we go from here?CRC Crit Rev Bioeng. 1978;3(2):149-79. CRC Crit Rev Bioeng. 1978. PMID: 83218 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources